Streetbeat News

Stock Prices

XLMDF

XLMedia PLC's shares fell sharply on London's AIM market as the company announced plans to wind up and return cash to shareholders, transforming into a non-trading cash shell.

Portfolio Pulse from

December 16, 2024 | 9:45 am

QS

RIVN

The article discusses two high-risk, high-reward electric vehicle (EV) stocks, QuantumScape and Rivian Automotive, as potential long-term investments for risk-tolerant investors. These stocks have the potential for significant gains or losses.

Portfolio Pulse from

December 16, 2024 | 9:45 am

NVDA

The S&P 500 has experienced a strong year, entering bull territory and achieving multiple record highs, with a projected 26% annual increase. This has been particularly beneficial for AI stocks, which have seen significant growth.

Portfolio Pulse from

December 16, 2024 | 9:30 am

PFE

Pharmaceutical and biotech stocks are considered stable investments due to consistent demand for medications, making them potentially strong performers through 2030.

Portfolio Pulse from

December 16, 2024 | 9:30 am

FIGS

FIGS, a company with strong free cash flow and no debt, has received a $6 per share offer from Story3 Capital to take it private. This offer is seen as undervaluing the company, which has seen its stock drop from over $35 to $6.07 since its IPO.

Portfolio Pulse from

December 16, 2024 | 9:00 am

PTLO

Portillo's, a fast-casual restaurant chain, is expanding rapidly despite declining comparable sales. The company aims to grow from 90 to 920 locations, focusing on the Sunbelt region. The stock has dropped 40.3% YTD, presenting a potential buying opportunity under $10, with an upside to $12.

Portfolio Pulse from

December 16, 2024 | 8:30 am

ALT

Altimmune is entering the obesity and MASH markets with Pemvidutide, a GLP-1/Glucagon dual-agonist drug. The drug offers fat-specific weight loss and muscle preservation with a strong safety profile. Altimmune is positioning Pemvidutide in unique market categories, suggesting the company is undervalued at current share prices.

Portfolio Pulse from

December 16, 2024 | 8:30 am

TSLA

Tesla's stock has surged significantly post-2024 election, driven by Elon Musk's ties with Trump and potential deregulation benefits. Favorable regulatory changes and growth in China could boost Tesla's market performance in 2025, with forecasted delivery growth and strong margins supporting continued momentum.

Portfolio Pulse from

December 16, 2024 | 8:30 am